Biopharm Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.50 Cr
- Revenue Growth 986.19%
- Profit Growth 671.32%
- Ebitda 378.64%
- Net Worth 713.38%
- Total Assets -60.24%
About Biopharm Solutions
Biopharm Solutions Private Limited (BSPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 March 2019 (Five years and 11 months 19 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sonika Bhatnagar and Santosh Kumar serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2019PTC322314
- Company No.
322314
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Biopharm Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonika Bhatnagar  | Director | 08-Mar-2019 | Current |
| Santosh Kumar | Director | 08-Mar-2019 | Current |
Financial Performance of Biopharm Solutions.
Biopharm Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 986.19% increase. The company also saw a substantial improvement in profitability, with a 671.32% increase in profit. The company's net worth Soared by an impressive increase of 713.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biopharm Solutions?
In 2023, Biopharm Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kemsolvs Solutions Private LimitedSonika Bhatnagar is a mutual person
- Labsolv Solutions Private Limited
Santosh Kumar is a mutual person
Charges (Loans)
₹0
₹35.00 M
Charges Breakdown by Lending Institutions
- Others : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Dec 2020 | Others | ₹1.75 Cr | Satisfied |
| 31 Oct 2019 | Others | ₹1.75 Cr | Satisfied |
How Many Employees Work at Biopharm Solutions?
Unlock and access historical data on people associated with Biopharm Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biopharm Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biopharm Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.